Intelligence Platform
Patents
Browse 89 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12427160
Use of cannabinoids in the treatment of epilepsy
granted patentUS 12403136
Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation th
granted patentUS 12396963
Cannabidiol-type cannabinoid compound
granted patentUS 12383512
Cannabidiol-type cannabinoid compound
granted patentUS 12383567
Use of cannabinoids in the treatment of epilepsy
granted patentUS 12364670
Cannabidiol-type cannabinoid compound
granted patentUS 12357586
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epilepti
granted patentUS 12350253
Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease
granted patentUS 12318356
Use of cannabinoids in the treatment of epilepsy
granted patentUS 12304912
Fused bicyclic RAF inhibitors and methods for use thereof
granted patentUS 12263139
Use of cannabidiol in the treatment of tuberous sclerosis complex
granted patentUS 12213985
Oral cannabinoid formulations
granted patentUS 12161620
Devices and methods for facilitating and controlling use of a medication
granted patentUS 12161607
Combination of cannabinoids in the treatment of leukemia
granted patentUS 12138233
Methods of treating idiopathic hypersomnia
granted patentUS 12121571
Recombinant L-asparaginase
granted patentUS 12102619
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
granted patentUS 12064398
Parenteral formulations
granted patentUS 12064399
Use of cannabinoids in the treatment of epilepsy
granted patentUS 11986446
Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
granted patentUS 11980636
Treatment of hematological disorders
granted patentUS 11858930
Fused bicyclic RAF inhibitors and methods for use thereof
granted patentUS 11802279
Modified L-asparaginase
granted patentUS 11571440
Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicit
granted